This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROBERT D. TAYLOR, M.D.; A. C. CORCORAN, M.D.; HARRIET P. DUSTAN, M.D.; IRVINE H. PAGE, M.D.

AMA Arch Intern Med. 1954;93(5):705-712.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

HYDRALAZINE has come into wide use in treatment of hypertensive disease during the past two years. Opinions as to its usefulness, practicality, and even as to its effectiveness are still widely varied. Thus, we¹ found that one-half of a group of patients, many of them with severe disease, responded favorably to its administration over periods of 3 to 12 months; more recently, Hilker, Rhoads, and Billings² reported a similar incidence of benefit and recommended the drug as a moderately effective antipressor agent useful in office practice. Johnson³ found it an effective hypotensive agent in 65% of his patients treated on an ambulatory basis. However, others* find it of limited value; some use it largely as an adjuvant in association with other antipressor drugs, and some⁹ consider it quite ineffective.

In this report we shall describe observations in our previously studied patient group which will demonstrate the effect of 14 further . . . [Full Text PDF of this Article]

Author Affiliations
CLEVELAND

From the Research Division of the Cleveland Clinic Foundation and the Frank E. Bunts Educational Institute.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?